PDS Biotechnology Corporation
Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions

Abstract:

The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor. The disclosure also provides methods of reducing an immune suppressor cell population in a mammal, methods of argumenting an immune response in a mammal, and methods of treating a diseases in a mammal utilizing the vaccine compositions.